Erlocip 100mg Tablet
Prescription Required
Marketed By
cipla
Pack of
30 tablet
Salt Composition
Erlotinib
Storage
Keep in cold place
₹3310₹6145.15
46.14% Off
Inclusive of all taxes
1
Erlocip 100mg Tablet
Delivering To: —
All Substitutes
Indication
non-small cell lung cancer (NSCLC) and pancreatic cancer
Description
Erlocip 100mg Tablet is a Target therapy based anticancer medication prescribed by the doctor to treat advanced Non Small Cell Lung Cancer (NSCLC) with specific EGFR gene mutation as well as Pancreatic Cancer in combination with other medicine. Erlotero 150mg tablet contains Erlotinib that blocks cancer cell growth and proliferation via angiogenesis.
Common Side Effects
Erlocip 100mg Tablet is a chemical based anti cancer medication. Like any other chemotherapeutic drug, it also has multiple side effects that range from common to extreme. Consult your doctor, if symptoms persists for longer period of time or if you experience any of the serious side effects.
● Vomiting
● Nausea
● Fatigue
● Diarrhea
● Decreased Appetite
● Abdominal Pain
● Dry Skin
● Mouth Sores
● Constipation
● Rashes
● Weight Loss
● Headache
● Arthralgia
● Dyspnea
● Pneumonitis
● Vision Related Issues
Dosage And Administration
The standard recommended starting dosage of Erlocip 100mg Tablet is once daily. This medicine is taken orally as whole on an empty stomach, without breaking, biting or chewing. Consult your doctor for exact dosage that is especially meant for you.
Mechanism Of Action
Erlocip 100mg Tablet contains Erlotinib that belongs to the class of tyrosine kinase inhibitor. Erlitinib blocks the abnormal EGFR protein kinase that is responsible for cancer cell growth and proliferation via angiogenesis. Abnormal EGFR protein blockage inhibits cancer cell growth.
Faqs
Erlocip 100mg Tablet cause harm to growing fetus as well as is teratogenic in nature. Thus, it is not recommended during pregnancy for treatment.
Yes, Erlocip 100mg Tablet is can be given with other chemotherapeutic drugs only under clear medical supervision. As it can have certain side effects on interacting with other drugs. Consult your doctor about the same.
Take Erlocip 100mg Tablet as soon as you remember it unless it is the time for the next dose. Do not double the dosage. Also inform your doctor about the missed dose.
Erlocip 100mg Tablet is taken orally with water without breaking, chewing or biting the tablet. It should be taken on an empty stomach. Follow the doctor's prescribed dosage and time.
Erlocip 100mg Tablet is used to treat advanced Non Small Cell Lung Cancer (NSCLC) with specific EGFR gene mutation as well as Pancreatic Cancer in combination with other medicine.
References
• Becker, A., van Wijk, A., Smit, E. F., & Postmus, P. E. (2010). Side-effects of long-term administration of erlotinib in patients with non-small cell lung cancer. Journal of Thoracic Oncology, 5(9), 1477-1480.
• Tang, P. A., Tsao, M. S., & Moore, M. J. (2006). A review of erlotinib and its clinical use. Expert opinion on pharmacotherapy, 7(2), 177-193.
• Abdelgalil, A. A., Al-Kahtani, H. M., & Al-Jenoobi, F. I. (2020). Erlotinib. In Profiles of drug substances, excipients and related methodology (Vol. 45, pp. 93-117). Academic Press.
• Gridelli, C., Bareschino, M. A., Schettino, C., Rossi, A., Maione, P., & Ciardiello, F. (2007). Erlotinib in non-small cell lung cancer treatment: current status and future development. The oncologist, 12(7), 840-849.
Related Products
MARKETER DETAILS
cipla
DISCLAIMER
The contents of this website are for informative purposes only. They are not deliberated to be an alternative to any professional medical prescription and treatment. Seek the advice of a qualified health provider for questions regarding the medical condition. Do not ignore any professional medical advice because of something you have read on this website. This website offers links to other websites, thereby enabling you to go to the other website directly. Therefore, Magicine Pharma isn't responsible for the content of the links in the website or links in the linked websites. The links are provided to assist the visitors and are not approved by any professional health provider.